Seroprevalence of antibodies against hepatitis A virus and hepatitis B virus in nonvaccinated adult population over 40 years of age;Séroprevalence potilátek proti viru hepatitidy A, viru hepatitidy B u nevakcinované dospělé populace starší 40 let

Epidemiologie, Mikrobiologie, Imunologie

Volumn 55, Issue 3, 2006, Pages 99-104

  Chlíbek, Roman ^a   Cecetkova B ^b   Smetana, J ^a   Prymula, R ^a   Kohl, I ^c  

^a Katedra Toxikologic Fakulty Vojenského Zdravotnictví UO   (Czech Republic)

^b Nemocnice s Polikliniko   (Czech Republic)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Antibodies; Seroprevalence; Viral hepatitis A; Viral hepatitis B

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ADULT; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CHEMOLUMINESCENCE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CZECH REPUBLIC; FEMALE; HEPATITIS A; HEPATITIS B; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; SCREENING TEST; SEROLOGY; SEROPREVALENCE; SEX DIFFERENCE; BLOOD; EPIDEMIOLOGY; MIDDLE AGED; VACCINATION;

ADULT; CZECH REPUBLIC; FEMALE; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS B; HEPATITIS B ANTIBODIES; HUMANS; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; VACCINATION;

EID: 33747270759     PISSN: 12107913     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Batra, Y., Bhatkal, B., Ojha, B., Kaur, K., Saraya, A. et al. Vaccination against hepatitis A virus may not be required for schoolchildren in northern India: results of a seroepidemiological survey. Bull World Health Organ., 2002, 80, 9, 728-731.
2. Devroey, D., Van Castern, V., Vranckx, R. Clinical acute viral hepatitis encountered by Belgian general practitioner. Inter J Infect Dis, 1997, 2, 105-109.
3. Fathalla, S. E., Al-Jama, A. A., Al-Sheikh, I. H., Islam, S. I. Seroprevalence of hepatitis A virus markers in Eastern Saudi Arabia. Saudi Med J, 2000, 21, 10, 945-949.
4. Gandolfo, G.M., Ferri, G.M., Conti, L., Antenucci, A. et al. Prevalence of infections by hepatitis A, B, C and E viruses in two different socioeconomic groups of children from Santa Cruz, Bolivia. Med Clin (Barc.), 2003, 120, 19, 725-727.
5. Himman, A. Eradication of vaccine-preventable disease. Ann Rev Public Health, 1999, 20, 211-229.
6. Chodick, G., Ashkenazi, S., Aloni, H., Peled, T. et al. Hepatitis A virus seropositivity among hospital and community healthcare workers in Israel - the role of occupation, demografy and socioeconomic background. Journal of Hospital Infection, 2003, 54, 135-140.
7. Jacobs, R. J., Saab, S., Meyerhoff, A. S., Koff, R. S. An economic assessment of pre-vaccination screening for hepatitis A and B. Public Health Rep., 2003, 118, 6, 550-558.
8. Lemon, S.M. Type A viral hepatitis: new developments in an old disease. New Engl J Med, 1985, 313, 1059-1067.
9. Louisirirotchanakul, S., Myint, K. S., Srimee, B., Kanoksinsombat, C. et al. The prevalence of viral hepatitis among the people of northern Thailand. Southeast Asian J Trop Med Public Health, 2002, 33, 4, 837-844.
10. Moses, S., Mestery, K., Kaita, K. D., Minuk, G. Y. Viral hepatitis in a Canadian street-involved population. Can J Public Health, 2002, 93, 2, 123-128.
11. Němeček, V. Sérologický přehled ČR v roce 2001 - virová hepatitida A, B, C. Zprávy CEM, 2003, 12, září, příloha 1, 55-59.
12. Papaevangelou, G. Epidemiology of hepatitis A in Mediterranean countries. Vaccine, 1992, 10 (Suppl.1), 63-66.
13. Plans-Rubio, P. Critical prevalence of antibodies minimizing vaccination costs for hepatitis A, hepatitis B, varicella, measles and tetanus in adults and adolescents in Catalonia, Spain. Vaccine, 2004, 22, 29-30, 4002-4013.
14. Ratanasuwan, W., Sonji, A., Tiengrim, S., Techasathit, W., Suwanagool, S. Serological survey of viral hepatitis A, B, and C at Thai Central Region and Bangkok: a population base study. Southeast Asian J Trop Med Public Health, 2004, 35, 2, 416-420.
15. Roy, E., Haley, N., Leclerc, P., Cedras, L., Bedard, L., Allard, R. Seroprevalence and risk factors for hepatitis A among Montreal street youth. Can J Public Health, 2002, 93, 3, 232.
16. Rožnovský, L., Kloudová, A., Dlhý, J. et al. Sérologický přehled a vakcinace proti virové hepatitidě A u zdravotníku na infekční klinice v Ostravě. Epidemiol Mikrobiol Imunol, 2005, 54, 3, 129-136.
17. Rufat, P., Dumouchel, P., Cadranel, J. F. Seroprevalence of hepatitis A and cost evaluation of different vaccination strategies against hepatitis A virus in patients with chronic hepatitis C in France. Gastroenterol Clin Biol, 2002, 26, 3, 256-260.
18. Sherlock, S. Hepatitis B: the disease. Vaccine, 1990, 8, 6S-9S.
19. Siddiqui, F., Mutchnick, M., Kinzie, J., Peleman, R. et al. Prevalence of hepatitis A virus and hepatitis B virus immunity in patients with polymerase chain reaction-confirmed hepatitis C: implications for vaccination strategy. Am J Gastroenterol, 2001, 96, 3, 858-863.
20. Soogarun, S., Wiwanitkit, V. Vaccinating Thai adolescents against hepatitis A: is it cost-effective? Southeast Asian J Trop Med Public Health, 2002, 33, Suppl 3, 145-148.
21. Steffen, R., Kane, M. A., Shapiro, C. N., Billo, N. et al. Epidemiology and Prevention of Hepatitis A in Travellers. JAMA, 1994, 272, 885-889.
22. Thiefelder, W., Hellenrand, W., Mesiel, H., Schreier, E., Dortschy, R. Prevalence of markers for hepatitis A, B and C in the German population. Results of the German national Health Interview and examination survey 1998. Eur J Epidemiol, 2001, 17, 429-435.
23. Vardas, E., Ross, M. H., Sharp, G., McAnerney, J., Sim, J. Viral hepatitis in South Affican healthcare workers at increased risk of occupational exposure to blood-borne viruses. J Hosp Infect, 2002, 50, 1, 6-12.